entertainment -WSS

entertainment

author：hotspot 2025-10-02 17:22:05 - browse：71122

A collage illustration with a patient in the center with a hand to the left administering treatment and a doctor in the background. -- health tech coverage from STAT — Katy Lemay for STAT

The makers of minimally invasive surgical devices seemed poised to capture a wide swath of the obesity treatment market. Patients needed an option that lay between the two treatment extremes: cutting open the abdomen to perform permanent bariatric surgery, or changing your diet or exercise routine.

Then, a new class of weight loss medications that successfully mimic the feeling of fullness hit the market, and the landscape changed.

“It turns out that what came along — before those endoscopic devices have really matured — is these new drugs,” said Lee Kaplan, director of Massachusetts General’s obesity institute. Since the Food and Drug Administration approved Novo Nordisk’s Wegovy in 2021, it and similar drugs that followed have swiftly captured the public’s interest — and are on their way to generating billions of dollars in sales.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Apple is now the first public company to be valued at $3 trillion
Next article： California’s proposed $25 per hour health care minimum wage

leisure time

WSS

Dozens of Pride flags vandalized at Stonewall monument in NYC, 3rd time this month: Police

Readout Newsletter: Medeor's stem cell study, Moderna's stock dip

Petition to FDA: Get the lead out of consumer hair dyes

Kidney transplant patients stopped immunosuppressants in trial

Live blog: Hearing on CRISPR

Lung cancer screening guidelines updated for cigarette smokers

leisure time

entertainment

focus

Medical leaders decry Supreme Court decision on affirmative action

Humans aren't the only ones with an imagination. Rats have it too

Medical records are filled with copy

After Sarepta trial failure, Duchenne families brace for more debate

Medical leaders decry Supreme Court decision on affirmative action

Charles Manson follower Leslie Van Houten released from prison after 53 years

At least 13 dead in Texas as scorching temps continue

What to know about OceanGate, the company behind the missing Titanic submersible

Continuity nursing helped my family in our darkest PICU moments

STAT Readout: The latest on Wegovy, Mounjaro, and Covid shots

Wikipedia

Gene therapy’s promise and the high cost of hope

Charles Manson follower Leslie Van Houten released from prison after 53 years

Sarepta Duchenne therapy fails to meet primary endpoint in trial

Why 40% Americans with Parkinson’s don’t see a neurologist

Charles Manson follower Leslie Van Houten released from prison after 53 years

DOJ reversal could clear way for Carroll's 1st lawsuit against Trump to proceed

leisure time

leisure time

hotspot

hotspot